The visit focused on evaluating pathways for Dalong products to enter the Malaysian market. Both parties engaged in substantive discussion on current product formulations and manufacturing technologies, and exchanged valuable professional insights on product optimization and upgrading to meet local market demands — providing an important reference framework for enhancing market fit.
Regarding the international expansion of Dalong Biotech’s own brand “NUMA,” both parties also explored potential promotional strategies. By assessing local distribution channel resources in Malaysia and identifying a preliminary product portfolio, the aim is to precisely connect with the local consumer market and create sustainable retail demand.
This exchange strengthened the foundation of mutual trust between both parties and opened a meaningful dialogue window for Dalong Biotech’s Southeast Asian market strategy. Going forward, we will continue to uphold our core commitment to professional R&D, maintain close communication with international partners, and actively pursue collaborative opportunities to bring Taiwan’s high-quality functional health products to the global stage.
